← Back to Patent Explorer
US6582936B1 Expired / Lapsed US ⏱️ 0.0 years remaining

Methods for making nucleic acids

Assignee: University of California, San Diego
•
Filing: 2000-05-08
•
Granted: 2003-06-24
•
Expires: 2020-05-08
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Nucleic acids are made by converting a primed single-stranded DNA to a double-stranded DNA by a method comprising the step contacting the single-stranded DNA with a DNA polymerase having 5' exonuclease activity under conditions whereby the DNA polymerase converts the-single stranded DNA to the double-stranded DNA, wherein the single-stranded DNA is primed with oligonucleotide primer comprising a sequence complementary to the 3' end of the single-stranded DNA, and at least one of the 5' end of the primer and the single-stranded DNA comprises an RNA polymerase promoter joined to an upstream (5') flanking moiety which protects the promoter from the 5' exonuclease activity of the DNA polymerase.

Inventors

  • 👤 Tito Serafini
  • 👤 Percy Luu
  • 👤 John Ngai
  • 👤 David Lin

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 04:20
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/68; C12Q1/6844; C12Q1/6853; C12N; C12N15/00; C12N15/09; C12N15/10; C12N15/1096; C12Q1/6809

Claims Analysis

Total Claims: 30
Claim 1
Independent Claim 116 words
A method for making a nucleic acid comprising the step of: converting a primed single-stranded DNA to a double-stranded DNA by a method comprising the step of contacting the single-stranded DNA with a DNA polymerase having 5′ exonuclease activity under conditions whereby the DNA polymerase converts the single-stranded DNA to the double-stranded DNA, wherein the 5′ end of the single-stranded DNA comprises an RNA polymerase promoter joined to an upstream (5′) flaking moiety which protects the promoter from the 5′ exonuclease activity of the DNA polymerase, wherein the upstream flanking moiety is selected from the group consisting of a dye, nucleotides −50 to −16 of the T7 promoter, modified nucleotide, a sterol, and an affinity tag.
Claim 2
Independent Claim 116 words
A method for making a nucleic acid comprising the step of: converting a primed single-stranded DNA to a double-stranded DNA by a method comprising the step of contacting the single-stranded DNA with a DNA polymerase having 5′ exonuclease activity under conditions whereby the DNA polymerase converts the single-stranded DNA to the double-stranded DNA, wherein the 5′ end of the single-stranded DNA comprises an RNA polymerase promoter joined to an upstream (5′) flaking moiety which protects the promoter from the 5′ exonuclease activity of the DNA polymerase, wherein the upstream flanking moiety is selected from the group consisting of a dye, nucleotides −50 to −16 of the T7 promoter, modified nucleotide, a sterol, and an affinity tag.
Claim 3
Dependent Claim 29 words
A method according to claim 1 , wherein the RNA polymerase promoter is selected from the group consisting of a T7, a T3 and an SP-6 RNA polymerase promoter.
Claim 4
Dependent Claim 16 words
A method according to claim 1 , wherein the RNA polymerase promoter comprises SEQ ID NO:1.
Claim 5
Dependent Claim 30 words
A method according to claim 1 , wherein the upstream flanking moiety is selected from the group consisting of a dye, a modified nucleotide, a sterol, and an affinity tag.
Claim 6
Dependent Claim 25 words
A method according to claim 1 , wherein the upstream flanking moiety is selected from the group consisting of fluorescein, rhodamine, digoxigenin, cholesterol and biotin.
Claim 7
Dependent Claim 14 words
A method according to claim 1 , wherein the upstream flanking moiety is biotin.
Claim 8
Dependent Claim 30 words
A method according to claim 1 , wherein the RNA polymerase promoter comprises SEQ ID NO:1 and the upstream flanking moiety is nucleotides −50 to −16 of the T7 promoter.
Claim 9
Dependent Claim 18 words
A method according to claim 1 , further comprising the step of repeatedly transcribing the double stranded DNA.
Claim 10
Dependent Claim 64 words
A method according to claim 1 , wherein the primed single-stranded DNA is made by the steps of: reverse transcribing an RNA to form a heterohybrid of the RNA and the single-stranded DNA; and nicking the RNA with an RNA endonuclease under conditions whereby the single-stranded DNA retains a 5′ most fragment of the RNA hybridized at the 3′ end of the single-stranded DNA.
Claim 11
Dependent Claim 37 words
A method according to claim 9 , wherein the RNA is mRNA and the reverse transcribing step comprises hybridizing to a 3′ poly(A) tail of the mRNA a poly(T) oligonucleotide joined to the RNA polymerase promoter sequence.
Claim 12
Dependent Claim 49 words
A method according to claim 9 , wherein the RNA is aRNA made by amplifying an mRNA and the reverse transcribing step comprises adding a known sequence onto the 3′ end of the aRNA, hybridizing to the known sequence a complementary oligonucleotide joined to the RNA polymerase promoter sequence.
Claim 13
Dependent Claim 52 words
A method according to claim 9 , wherein the RNA is aRNA made by amplifying an mRNA and the reverse transcribing step comprises using polyadenyltransferase to add a known sequence onto the 3′ end of the aRNA, hybridizing to the known sequence a complementary oligonucleotide joined to the RNA polymerase promoter sequence.
Claim 14
Dependent Claim 54 words
A method according to claim 9 , wherein the RNA is aRNA made by amplifying an mRNA and the reverse transcribing step comprises using polyadenyltransferase to add a poly(A) tail onto the 3′ end of the aRNA, hybridizing to the poly(A) tail sequence a complementary poly(T) oligonucleotide joined to the RNA polymerase promoter sequence.
Claim 15
Dependent Claim 29 words
A method according to claim 9 , wherein the RNA polymerase promoter is selected from the group consisting of a T7, a T3 and an SP-6 RNA polymerase promoter.
Claim 16
Dependent Claim 28 words
A method according to claim 9 , wherein the upstream flanking moiety is selected from the group consisting of a dye, modified nucleotide, a sterol, and affinity tag.
Claim 17
Dependent Claim 25 words
A method according to claim 9 , wherein the upstream flanking moiety is selected from the group consisting of fluorescein, rhodamine, digoxigenin, cholesterol and biotin.
Claim 18
Dependent Claim 14 words
A method according to claim 9 , wherein the upstream flanking moiety is biotin.
Claim 19
Dependent Claim 16 words
A method according to claim 9 , wherein the RNA polymerase promoter comprises SEQ ID NO:1.
Claim 20
Dependent Claim 30 words
A method according to claim 9 , wherein the RNA polymerase promoter comprises SEQ ID NO:1 and the upstream flanking moiety is nucleotides −50 to −16 of the T7 promoter.
Claim 21
Dependent Claim 18 words
A method according to claim 9 , further comprising the step of repeatedly transcribing the double stranded DNA.
Claim 22
Independent Claim 138 words
A method for making a nucleic acid comprising the step of: converting a primed single-stranded DNA to a double-stranded DNA by a method comprising the step of contacting the single-stranded DNA with a DNA polymerase having 5′ exonuclease activity under conditions whereby the DNA polymerase converts the single-stranded DNA to the double-stranded DNA, wherein the single-stranded DNA is primed with an oligonucleotide primer comprising a sequence complementary to the 3′ end of the single-stranded DNA and the 5′ end of the primer comprises an RNA polymerase promoter joined to an upstream (5′) flanking moiety which protects the promoter from the 5′ exonuclease activity of the DNA polymerase, wherein the upstream flanking moiety is selected from the group consisting of a dye, nucleotides −50 to −16 of the T7 promoter a modified nucleotide, a sterol, and an affinity tag.
Claim 23
Independent Claim 138 words
A method for making a nucleic acid comprising the step of: converting a primed single-stranded DNA to a double-stranded DNA by a method comprising the step of contacting the single-stranded DNA with a DNA polymerase having 5′ exonuclease activity under conditions whereby the DNA polymerase converts the single-stranded DNA to the double-stranded DNA, wherein the single-stranded DNA is primed with an oligonucleotide primer comprising a sequence complementary to the 3′ end of the single-stranded DNA and the 5′ end of the primer comprises an RNA polymerase promoter joined to an upstream (5′) flanking moiety which protects the promoter from the 5′ exonuclease activity of the DNA polymerase, wherein the upstream flanking moiety is selected from the group consisting of a dye, nucleotides −50 to −16 of the T7 promoter a modified nucleotide, a sterol, and an affinity tag.
Claim 24
Dependent Claim 29 words
A method according to claim 21 , wherein the RNA polymerase promoter is selected from the group consisting of a T7, a T3 and an SP-6 RNA polymerase promoter.
Claim 25
Dependent Claim 30 words
A method according to claim 21 , wherein the upstream flanking moiety is selected from the group consisting of a dye, a modified nucleotide, a sterol, and an affinity tag.
Claim 26
Dependent Claim 25 words
A method according to claim 21 , wherein the upstream flanking moiety is selected from the group consisting of fluorescein, rhodamine, digoxigenin, cholesterol and biotin.
Claim 27
Dependent Claim 14 words
A method according to claim 21 , wherein the upstream flanking moiety is biotin.
Claim 28
Dependent Claim 16 words
A method according to claim 21 , wherein the RNA polymerase promoter comprises SEQ ID NO:1.
Claim 29
Dependent Claim 30 words
A method according to claim 21 , wherein the RNA polymerase promoter comprises SEQ ID NO:1 and the upstream flanking moiety is nucleotides −50 to −16 of the T7 promoter.
Claim 30
Dependent Claim 18 words
A method according to claim 21 , further comprising the step of repeatedly transcribing the double stranded DNA.

References Cited (Backward Citations)

US5753433A Cited
US4952496A Cited
US5554517A Cited
US5741637A Cited
WO1991018115A1 Cited
JPH05500012A Cited
US5514545A Cited
WO1996036733A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2006-06-23 2006-12-23 2007-06-24 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2010-06-23 2010-12-23 2011-06-24 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2014-06-23 2014-12-23 2015-06-24 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag